Abstract
AbstractIntroductionThe effects of the coronavirus disease 2019 (COVID‐19) pandemic on scholarly outcomes and research focus of schools of pharmacy (SOPs) have not been studied.ObjectivesTo determine how objective measures of scholarly outcomes and research focus changed in pharmacy practice among SOPs, within geographic regions, during the COVID‐19 pandemic.MethodsSOPs were included if they appeared on the National Institutes of Health (NIH) funding list in all four index years (2018–2019: pre‐pandemic and 2020–2021: pandemic) and ranked among the top 50 at least once between 2018 and 2021. Names of pharmacy practice faculty were obtained from the American Association of Colleges of Pharmacy (AACP) directory. The publication records of each SOP were obtained from Scopus. Scholarly outcome measures were scholarly activity ratio (SAR; proportion of faculty members who published) and scholarly output (SO; number of documents published). Data was analyzed using Microsoft Excel, VOSviewer®, and Python. Statistical analysis was done in R using a mixed effects model, with the pandemic and geographic regions as fixed effects, and SOPs as the random effect.ResultsFifty‐five SOPs and 1343 faculty members were included. Neither the pandemic nor geographic region had significant effects on SAR. However, both variables had significant effects on SO, as demonstrated by an increase in the Midwest during the pandemic (p < 0.05). Documents published increased from 2755 to 3001 during the pandemic. This 8.9% increase was lower than a historical average biennial increase of 24.9%. COVID‐19 was the top new research topic, constituting 56.5% of the increase over the pre‐pandemic period. Of these COVID‐19 publications, 20.9% were education‐related.ConclusionPharmacy practice faculty engaged in COVID‐19 research that focused predominantly on education. Scholarly‐active faculty were resilient, but their output was lower than expected based on historical trends. These results support the need to adjust tenure and promotion benchmarks and/or timelines related to scholarly output, especially for tenure‐track faculty with probationary periods spanning these pandemic years.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.